Latest Updates

Net Sales for the 12 months ended March 2017 grew by 7.9 per cent, the Board recommends a final dividend of Rs 25/- per share

Tildrakizumab is being evaluated for treatment of moderate-to-severe plaque psoriasis

During FY 2016-2017 total income stood at ₹ 726.4 crore in comparison to ₹ 770.8 crore recorded in the previous corresponding…

It is a monoclonal antibody developed for the treatment of solid tumours soft tissue sarcomas GNH India, pharmaceutical…

Enriched with 11 organic herbal actives, ITIS Plus Care Eye Drops brings relief to tired and irritated eyes

High Court of Delhi grants permanent injunction against the manufacture and sale of Sinopharm's amoxicillin active pharmaceutical…

Documentary evidence of communication may protect manufacturers from the claim of overcharging the medicine

The initiative has been rolled out in five states and by next month, it will be introduced in 17 more states Children suffering…

By Swati Rana-Mumbai Further clarifications are needed before it comes into force The much awaited Goods and Services Tax (GST)…

Boehringer Ingelheim, a global pharma major, recently announced its plans to strategically realign its business focus areas.…